HomeMDG1 • ETR
add
MediGene AG
Previous close
€1.55
Day range
€1.46 - €1.59
Year range
€1.28 - €2.74
Market cap
44.07M EUR
Avg Volume
54.89K
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.48M | -50.19% |
Operating expense | 5.51M | 42.24% |
Net income | -4.60M | 58.62% |
Net profit margin | -310.00 | 16.92% |
Earnings per share | — | — |
EBITDA | -4.24M | -148.75% |
Effective tax rate | -3.53% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.67M | -49.81% |
Total assets | 31.72M | -38.63% |
Total liabilities | 10.65M | -27.31% |
Total equity | 21.07M | — |
Shares outstanding | 24.56M | — |
Price to book | 1.80 | — |
Return on assets | -34.59% | — |
Return on capital | -45.68% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.60M | 58.62% |
Cash from operations | -3.54M | -33.03% |
Cash from investing | -85.50K | 77.96% |
Cash from financing | -306.50K | -2,454.17% |
Net change in cash | -3.94M | -27.88% |
Free cash flow | -2.54M | -127.72% |
About
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Founded
1994
Headquarters
Website
Employees
76